Table 3

Population prevalence of symptomatic foot OA by anatomical location and age, gender and socioeconomic classification

1st MTPJ1st CMJ2nd CMJNCJTNJOverall
Symptomatic radiographic OA7.8 (6.7 to 8.9)3.9 (2.9 to 4.9)6.8 (5.7 to 7.8)5.2 (4.0 to 6.4)5.8 (4.8 to 6.9)16.7 (15.3 to 18.0)
Males6.7 (5.3 to 8.0)3.6 (2.4 to 4.9)5.0 (3.8 to 6.2)3.8 (2.4 to 5.2)5.0 (3.4 to 6.7)14.3 (12.6 to 16.0)
Females8.8 (7.4 to 10.3)4.2 (2.9 to 5.4)8.5 (6.9 to 10.2)6.7 (5.0 to 8.3)6.6 (5.3 to 8.0)18.9 (16.9 to 20.9)
Age
 50–646.9 (5.5 to 8.2)4.1 (2.8 to 5.4)6.0 (4.6 to 7.4)4.8 (3.4 to 6.2)5.6 (4.1 to 7.1)15.9 (13.9 to 17.9)
 65–748.7 (6.6 to 10.8)3.5 (2.2 to 4.7)6.4 (4.8 to 7.9)4.9 (3.1 to 6.8)5.7 (4.1 to 7.2)17.0 (14.8 to 19.2)
 75+9.0 (6.7 to 11.2)3.9 (1.6 to 6.2)9.8 (7.2 to 12.5)7.0 (4.7 to 9.3)7.0 (4.8 to 9.1)18.5 (15.8 to 21.1)
Age, males
 50–645.8 (4.1 to 7.5)4.0 (2.3 to 5.7)4.6 (3.1 to 6.0)3.5 (1.9 to 5.2)5.0 (2.8 to 7.2)13.9 (11.5 to 16.3)
 65–748.0 (5.5 to 10.6)3.2 (1.3 to 5.2)4.6 (2.6 to 6.7)3.6 (1.7 to 5.6)4.6 (2.5 to 6.8)15.0 (12.0 to 18.0)
 75+7.1 (4.3 to 9.9)2.9 (0.3 to 5.4)7.2 (4.3 to 10.2)4.9 (2.1 to 7.6)5.9 (3.0 to 8.8)14.4 (10.8 to 18.1)
Age, females
 50–647.9 (6.1 to 9.8)4.3 (2.4 to 6.2)7.5 (5.0 to 10.0)6.1 (4.1 to 8.1)6.1 (4.3 to 7.9)17.9 (15.1 to 20.6)
 65–749.4 (6.5 to 12.3)3.7 (1.7 to 5.6)8.2 (6.0 to 10.4)6.3 (3.6 to 8.9)6.7 (4.1 to 9.4)19.0 (15.6 to 22.4)
 75+10.3 (7.3 to 13.4)4.7 (1.7 to 7.7)11.7 (8.0 to 15.5)8.6 (5.1 to 12.2)7.7 (4.8 to 10.6)21.4 (17.7 to 25.2)
Socioeconomic classification
 Managerial and professional4.8 (3.3 to 6.3)2.5 (0.8 to 4.1)3.7 (2.1 to 5.3)2.5 (0.9 to 4.2)3.8 (2.1 to 5.5)10.2 (8.0 to 12.5)
 Intermediate occupations8.7 (5.9 to 11.5)4.0 (1.0 to 7.0)6.9 (4.6 to 9.2)6.1 (3.7 to 8.6)6.1 (3.0 to 9.3)17.9 (14.7 to 21.1)
 Routine and manual8.3 (6.6 to 10.0)4.1 (2.9 to 5.4)7.3 (5.7 to 8.9)6.1 (4.6 to 7.6)6.4 (4.9 to 7.8)18.2 (16.2 to 20.1)
  • CMJ, cuneometatarsal joint; OA, osteoarthritis; MTPJ, metatarsophalangeal joint; NCJ, navicular first cuneiform joint; TNJ, talonavicular joint.